Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 6/20 | 0.36 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.35 |
| ▸ | LDHA | P00338 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | LDHB | P07195 | 1/20 | 0.35 |
| ▸ | ADRB2 | P07550 | 6/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.34 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.32 |
| ▸ | ERN1 | O75460 | 1/20 | 0.32 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22839830 | 0.75 | TDP1 (0.40) | ADRB2ADRB1DRD2ADRA1DADRB3 | |
| SCHEMBL22839967 | 0.74 | ADRB2 (0.40) | SLC16A3MEN1LMNAKMT2AADRB2 | |
| SCHEMBL22839800 | 0.72 | ADRB2 (0.49) | MEN1KMT2AADRB2CHRM3 | |
| SCHEMBL19903846 | 0.71 | ADRB2 (0.36) | HSD17B10SLC16A3MEN1LMNAKMT2A | |
| SCHEMBL22839971 | 0.71 | ADRB2 (0.49) | MEN1KMT2AADRB2CHRM3 | |
| SCHEMBL20373553 | 0.70 | SMN1; SMN2 (0.44) | MEN1LMNAKMT2AADRB2CHRM3 | |
| SCHEMBL22829216 | 0.67 | ADRB2 (0.69) | ADRB2CHRM3 | |
| SCHEMBL22829213 | 0.67 | ADRB2 (0.69) | ADRB2CHRM3 | |
| SCHEMBL19903850 | 0.66 | CHRM3 (0.39) | ADRB2CHRM3 | |
| SCHEMBL19784099 | 0.66 | ADRB2 (0.42) | ADRB2CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3484879-B1 | HYDROXYQUINOLINONE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY | CHIESI FARM SPA (IT) | 2020-12-30 | — | — | EP | disclosed |